Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT Filling Up With Cash

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Feb 07, 2022 10:30pm

364 Views

Post# 34407257

RE:RE:RE:TLT Filling Up With Cash

If Accelerated FDA (AA) approval is granted , then commercialisation would be way before 2025, my guess would be in about 15-18 months from now. 2025 is for regular full approval. BTD could open the door for a quick AA so long as data remains stellar IMO

Mikee3003 wrote: Hi Apophis - No disrespect, I believe there is some misunderstanding with what Breakthrough Designation really means. BTD will not allow Theralase to go into commercialization this year. Please see link below, in particular the following statement:

Breakthrough Therapy designation is eligible for the following:

All Fast Track designation features

Intensive guidance on an efficient drug development program, beginning as early as Phase 1

breakthrough-therapy

Of course everyone would like this to move quicker however there is a process that TLT needs to follow. Review page 13 of TLT's latest Corporate Presentation, it shows BTD is expected by mid 2022 then commercialization by 2025.

All the Best
Mikee